Altered energy metabolism in Alzheimer's disease

Journal of the Neurological Sciences

Volumn 139, Issue 1, 1996, Pages 78-82

  Ogawa, Masafumi ^b   Fukuyama, Hidenao ^a   Ouchi, Yasuomi ^a   Yamauchi, Hiroshi ^a   Kimura, Jun ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

Alzheimer's disease; Cerebral arteriovenous difference; Cerebral blood flow; Energy metabolism; Oxygen glucose utilization ratio; Single photon emission computed tomography

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0030200659     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(96)00033-0     Document Type: Article

References (23)

1. Bagley P.R., S.P. Tucker, C. Nolan, J.G. Lindsay, A. Davies, S.A. Baldwin, J.E. Cremer and V.J. Cunnimgham (1989) Anatomical mapping of glucose transporter protein and pyruvate dehydrogenase in rat brain. Brain Res., 499: 214-224.
2. Baron J.C., Ph. Lebrun-Grandie, Ph. Collard, C. Crouzel, G. Mestelan and M.G. Bousser (1982) Noninvasive measurement of blood flow, oxygen consumption, and glucose utilization in the same brain locus in man by positron emission tomography: concise communication. J. Nucl. Med., 23: 391-399.
3. Baron J.C., D. Rougemont, F. Soussaline, P. Bustany, C. Crouzel, M.G. Bousser and D. Comar (1984) Local interrelationships of cerebral oxygen consumption and glucose utilization in normal subjects and in ischemic stroke patients: A positron tomography study. J. Cereb. Blood Flow Metab., 4: 140-149.
4. Bradford H.F., K.K. Hedberg and O.H. Griffith (1969) Metabolism of glucose and glutamate by synaptosomes from mammalian cerebral cortex. J. Neurochem., 16: 1495-1504.
5. Cutler N.R., J.V. Haxby, R. Duara, C.L. Grady, A.D. Kay, R.M. Kessler, M. Sundaram and S.I. Rapoport (1985) Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease. Ann. Neurol., 18: 298-309.
6. Frackowiak R.S.J., C. Pozzilli, N.J. Legg, G.H. Du Boulay, J. Marshall, G.L. Lenzi and T. Jones (1981) Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain, 104: 753-778.
7. Friedland R.P., A. Brun and T.F. Budinger (1985) Pathological and positron emission tomographic correlations in Alzheimer's disease. Lancet, 1: 228.
8. Fukuyama H., M. Kameyama, K. Harada, S. Nishizawa, M. Senda, T. Mukai, Y. Yonekura and K. Torizuka (1989) Glucose metabolism and rate constants in Alzheimer's disease examined with dynamic positron emission tomography scan. Acta Neurol. Scand., 80: 307-313.
9. Fukuyama H., M. Ogawa, H. Yamauchi, S. Yamaguchi, J. Kimura, Y. Yonekura and J. Konishi (1994) Altered cerebral energy metabolism in Alzheimer's disease: A PET study. J. Nucl. Med., 35: 1-6.
10. Hasegawa K., K. Inoue and K. Moriya (1974) An investigation of dementia rating scale for the elderly (in Japanese). Seisin Igaku, 965-969.
11. Hoyer S. (1986) Senile dementia and Alzheimer's disease. Brain blood flow and metabolism. Prog. Neuropsychopharmacol. Biol. Psychiatry, 10: 447-478.
12. Hoyer S., K. Oesterreich and O. Wagner (1988) Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type? J. Neurol., 235: 143-148.
13. Jagust W.J., J.P. Seab, R.H. Huesman, P.E. Valk, C.A. Mathis, B.R. Reed, P.G. Coxson and T.F. Budinger (1991) Diminished glucose transport in Alzheimer's disease: Dynamic PET studies. J. Cereb. Blood Flow Metab., 11: 323-330.
14. Kalaria R.N. and S.I. Harik (1989) Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease. J. Neurochem., 53: 1083-1088.
15. 123I)iodoamphetamine (IMP) tomography. J. Nucl. Med., 23: 196-203.
16. Lying-Tunell U., B.S. Lindblad, H.O. Malmlund and B. Persson (1981) Cerebral blood flow and metabolic rate of oxygen, glucose, lactate, pyruvate, ketone bodies and amino acids. Acta Neurol. Scand., 63: 337-350.
17. Maslia E., D.S. Iimoto, T. Saitoh, L.A. Hansen and R.D. Terry (1990) Increased immunoreactivity of brain spectrin in Alzheimer disease: A marker for synapse loss? Brain Res., 531: 36-44.
18. McKhann G., D. Drachman, M. Flostein, R. Katzman, D. Price and E.M. Stadlan (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of Health and Human services task force on Alzheimer's disease. Neurology, 34: 939-944.
19. Pearce J.M.S. (1984) Dementia: A clinical approach. Oxford, Blackwell Scientific Publications. pp 27-31.
20. 14) glucose in vitro in human neocortex. J. Neurochem., 41: 1329-1334.
21. Sokoloff L. (1960) The metabolism of the cerebral nervous system in vivo. In: J. Field, H.W. Magoun and V.E. Hall (Eds.), Handbook of Physiology: Neurophysiology, vol III. American Physiological Society, Washington, D.C., pp 1843-1864.
22. Sokoloff L. (1976) Circulation and energy metabolism of the brain. In: G.J. Siegel, R. Albers, R. Katzman and B.W. Agranoff (Eds.), Basic Neurochemistry. 2nd edn., Little, Brown, Boston, pp 388-413.
23. Sorbi S., E.D. Bird and J.P. Blass (1983) Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann. Neurol., 13: 72-78.